Browse Title Index


 
Issue Title
 
Vol 23, No 3 (2016) Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? Abstract   PDF   HTML
P. Mondello, M. Mian, V. Pitini, S. Cuzzocrea, A. Sindoni, M. Galletti, M. Mandolfino, D. Santoro, S. Mondello, C. Aloisi, G. Altavilla, S. Benvenga
 
Vol 19, No 5 (2012) Time to put an end to the “one size fits all” approach to bisphosphonate use in patients with metastatic breast cancer? Details   PDF   HTML
I. Kuchuk, M. Clemons, C. Addison
 
Vol 24, No 5 (2017) Timeliness of the oncology drug review process for public funding in Canada Abstract   PDF   HTML
T. Younis, C. Skedgel
 
Vol 22, No 5 (2015) To screen or not to screen for breast cancer? How do modelling studies answer the question? Abstract   PDF   HTML
R.G. Koleva-Kolarova, Z. Zhan, M. J.W. Greuter, T. L. Feenstra, G. H. De Bock
 
Vol 19, No 4 (2012) Tobacco and health: with or without pictures, nothing redeems smoking Abstract   PDF   HTML
Louis Z. G. Touyz
 
Vol 20, No 5 (2013) Tony Pawson Abstract   PDF   HTML
Friends at McGill University
 
Vol 26, No 3 (2019) Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database Abstract   PDF   HTML
M. J. Passeri, E. H. Baker, I. A. Siddiqui, M. A. Templin, J. B. Martinie, D. Vrochides, D. A. Iannitti
 
Vol 19, No 3 (2012) Toward a portrait of Canadian cancer control Details   PDF   HTML
Heather Bryant
 
Vol 24, No 6 (2017) Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative Abstract   PDF   HTML
I. Harle, S. Karim, W. Raskin, W.M. Hopman, C.M. Booth
 
Vol 21, No 2 (2014) Toward successful migration to computerized physician order entry for chemotherapy Abstract   PDF   HTML
J. Jeon, S. Taneva, V. Kukreti, P. Trbovich, A.C. Easty, P.G. Rossos, J.A. Cafazzo
 
Vol 25, No 1 (2018) Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA) Abstract   PDF   HTML
M. Uccello, M. Moschetta, G. Mak, T. Alam, C. Murias Henriquez, H.-T. Arkenau
 
Vol 24, No 5 (2017) Training oncoplastic breast surgeons: the Canadian fellowship experience Abstract   PDF   HTML
J. Maxwell, A. Aranaout, R. Hanrahan, M. Brackstone
 
Vol 23, No 2 (2016) Training the trainer: five practical considerations for your first five years in practice Abstract   PDF   HTML
C. Jacobs, A.A. Joy, M. Clemons, S. Mazzarello, M. Fralick
 
Vol 24, No 1 (2017) Trastuzumab in metastatic breast cancer after complete remission: an expensive commitment for an entire life? Abstract   PDF   HTML
D. Bernardi, M. Stefani, M. Boccalon, C. Raiti
 
Vol 15, No 1 (2008) Trastuzumab in the adjuvant setting: concurrent vs. sequential? It takes two to tango! Details   PDF
Sunil Verma
 
Vol 15, No 3 (2008) Trastuzumab: a cardiologist’s perspective Details   PDF
Marc André Côté
 
Vol 24, No 3 (2017) Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population Abstract   PDF   HTML
M. Rushton, C. Johnson, S. Dent
 
Vol 15, No 5 (2008) Treating Recurrent Cases of Squamous Cell Carcinoma with Radiotherapy Details   PDF
Jennifer Jing-Wen Wong, Dale Breen, Judith Balogh, Gregory J Czarnota, Juhu Kamra, Elizabeth Antonia Barnes
 
Vol 25, No 5 (2018) Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus Abstract   PDF   HTML   Supplemental Material   Supplemental Material
M. Carrier, N. Blais, M. Crowther, P. Kavan, G. Le Gal, O. Moodley, S Shivakumar, V. Tagalakis, C. Wu, A.Y. Y. Lee
 
Vol 21, No 4 (2014) Treatment and follow-up strategies in desmoid tumours: a practice guideline Abstract   PDF   HTML
M. Ghert, X. Yao, T. Corbett, A.A. Gupta, R.A. Kandel, S. Verma, J. Werier
 
Vol 24, No 2 (2017) Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based study Abstract   PDF   HTML
E.R. Morgan, A. Norman, K. Laing, M.D. Seal
 
Vol 23, No 6 (2016) Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series Abstract   PDF   HTML
D.S. Tsang, L.W. Le, V. Kukreti, A. Sun
 
Vol 17, No 6 (2010) Treatment for glioblastoma multiforme: current guidelines and Canadian practice Abstract   PDF
A. Ghose, G. Lim, S. Husain
 
Vol 14, No 5 (2007) Treatment of Depression in Cancer Patients Details   PDF
Gary Rodin, Mark Katz, Nancy Lloyd, Esther Green, Rebecca K.S. Wong
 
Vol 19, No 6 (2012) Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations Abstract   PDF   HTML
S. L'Esperance, F. Vincent, M. Gaudreault, J.A. Ouellet, M. Li, A. Tosikyan, S. Goulet, Comité de l'évolution des pratiques en oncologie
 
Vol 23, No 3 (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives Abstract   PDF   HTML
J. Spiliotis, E. Halkia, E. de Bree
 
Vol 21, No 3 (2014) Treatment outcomes for male breast cancer: a single-centre retrospective case–control study Abstract   PDF   HTML
M. Rushton, A. Kwong, H. Visram, N. Graham, W. Petrcich, S. Dent
 
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line Abstract   PDF   HTML
N.B. Leighl
 
Vol 22, No 6 (2015) Treatment patterns among Canadian men diagnosed with localized low-risk prostate cancer Abstract   PDF   HTML
C. Sandoval, K. Tran, R. Rahal, G. Porter, S. Fung, C. Louzado, J. Liu, H. Bryant
 
Vol 23, No 6 (2016) Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective study Abstract   PDF   HTML
S. Kayaniyil, M. Hurry, J. Wilson, P. Wheatley-Price, B. Melosky, J. Rothenstein, V. Cohen, C. Koch, J. Zhang, K. Osenenko, G. Liu
 
Vol 24, No 4 (2017) Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study Abstract   PDF   HTML
A. Dragomir, J. Rocha, M. Vanhuyse, F.L. Cury, W. Kassouf, J. Hu, A.G. Aprikian
 
Vol 19, No 5 (2012) Treatment recommendations for the use of bone-targeted agents in 2011— report from the 6th Annual Bone and the Oncologist New Updates meeting Abstract   PDF   HTML
I. Kuchuk, A. Paterson, E. Amir, M. Clemons, N. Bouganim
 
Vol 26, No 2 (2019) Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot–Marie–Tooth disease Abstract   PDF   HTML
J. D. Bernstock, J. L. Cohen, S. Singh, C. W. Schlappi, J. B. Fiveash, J. M. Johnston, P. Fequiere, B. A. Orr, R. Li, G. K. Friedman
 
Vol 23, No 3 (2016) Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002–2009: a population-based cohort study Abstract   PDF   HTML
H.H. Thein, Y. Qiao, S.K. Young, W. Zarin, E.M. Yoshida, C. de Oliveira, C.C. Earle
 
Vol 18, No 4 (2011) Triple-negative and basal-like breast cancer: implications for oncologists Details   PDF   HTML
J. Lachapelle, W.D. Foulkes
 
Vol 18, No 4 (2011) Triple-negative breast cancers: an updated review on treatment options Abstract   PDF   HTML
K. B. Reddy
 
Vol 21, No 3 (2014) Truth be told— perspectives on openness Abstract   PDF   HTML
R.E. Hughes, J. Richards
 
Vol 22, No 1 (2015) Tumour inflammatory response: adding fuel to the fire? Abstract   PDF   HTML   Erratum
M. Valdes, M.R. Chasen
 
Vol 19, No 5 (2012) Tumour size predicts long-term survival among women with lymph node-positive breast cancer Abstract   PDF   HTML
S.A. Narod
 
Vol 15, No 5 (2008) Two Cases of Acrometastasis to the Hands and Review of the Literature Abstract   PDF
Candi J. Flynn, Cyril Danjoux, John Wong, Monique Christakis, Joel Rubenstein, Albert Yee, Darwin Yip, Edward Chow
 
Vol 21, No 6 (2014) Two cases of cutaneous drug eruption associated with temozolomide therapy for glioblastoma Abstract   PDF   HTML
E. Deluche, S. Leobon, F. Touraine, P. Clavère
 
Vol 21, No 3 (2014) Two indicators of hospital resource efficiency in cancer care Abstract   PDF   HTML
R. Rahal, J. Xu, S. Fung, H. Bryant
 
Vol 19, No 6 (2012) Ubiquitin pathway and ovarian cancer Abstract   PDF   HTML   CORRIGENDA
Z. Rao, Y. Ding
 
Vol 17, No 6 (2010) Umbilical metastasis: a case series of four Sister Joseph nodules from four different visceral malignancies Abstract   PDF
M. Palaniappan, W.M. Jose, A. Mehta, K. Kumar, K. Pavithran
 
Vol 21, No 5 (2014) Uncommon case of brain metastasis in a patient with a history of heavy smoking Abstract   PDF   HTML
M. Scharl, B. Bode, E. Rushing, A. Knuth, T. Rordorf
 
Vol 19, No 1 (2012) Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis Abstract   PDF   HTML
A. Bagnato, L. Rosanò
 
Vol 25, No 4 (2018) Understanding the reasons for provincial discordance in cancer drug funding— a survey of policymakers Abstract   PDF   HTML
A. Srikanthan, N. Penner, K.K.W. Chan, M. Sabharwal, A. Grill
 
Vol 25, No 4 (2018) Unnecessary variation in practice: how to improve cancer care through pragmatic trials Abstract   PDF   HTML
N. LeVasseur, D. Fergusson, M. Clemons
 
Vol 22, No 4 (2015) Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer Abstract   PDF   HTML
V. Kumar, Y. Xu
 
Vol 21, No 5 (2014) Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer Abstract   PDF   HTML
M.A. Socinski
 
Vol 14, No 4 (2007) Updated recommendations from the Canadian National consensus meeting on HER2/neu testing in breast cancer Abstract   PDF
Wedad Hanna, Frances P O’Malley, P Barnes, R Berendt, L Gaboury, A Magliocco, N Pettigrew, S Robertson, S Sengupta, B Têtu, T Thomson
 
Vol 24, No 1 (2017) Updates from the 2016 American Society of Hematology annual meeting: practice-changing studies in untreated follicular lymphoma Abstract   PDF   HTML
C. Owen, D. MacDonald, A. Aw, A. Christofides
 
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in relapsed and refractory mantle cell lymphoma Abstract   PDF   HTML
C. Owen, J. Kuruvilla, A. Christofides
 
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in untreated chronic lymphocytic leukemia Abstract   PDF   HTML
C. Owen, C. Toze, A. Christofides
 
Vol 24, No 2 (2017) Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists Abstract   PDF   HTML
M.A. O'Brien, S. Dhesy-Thind, C. Charles, M. Hammond Mobilio, N.B. Leighl, E. Grunfeld
 
Vol 18, No 3 (2011) Uptake of novel medical therapies in the general population Abstract   PDF   HTML
C. M. Booth, B. Rapoport
 
Vol 22, No 1 (2015) Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer Abstract   PDF   HTML
F. Santos, A. Dragomir, W. Kassouf, E. Franco, A. Aprikian
 
Vol 26, No 2 (2019) U.S. prevalence of endocrine therapy–naïve locally advanced or metastatic breast cancer Abstract   PDF   HTML
A. P. Nunes, C. Liang, W. J. Gradishar, T. Dalvi, J. Lewis, N. Jones, E. Green, M. Doherty, J. D. Seeger
 
Vol 19, No 4 (2012) Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience Abstract   PDF   HTML
X. Zhu, N. Bouganim, L. Vandermeer, S. F. Dent, G. Dranitsaris, M. J. Clemons
 
Vol 22, No 2 (2015) Use of bevacizumab as a first-line treatment for metastatic breast cancer Abstract   PDF   HTML
L. Manso, F. Moreno, R. Márquez, B. Castelo, A. Arcediano, M. Arroyo, A.I. Ballesteros, I. Calvo, M.J. Echarri, S. Enrech, A. Gómez, R. González del Val, E. López-Miranda, M. Martín-Angulo, N. Martínez-Jañez, C. Olier, P. Zamora
 
Vol 23 (2016): Use of Cannabinoids in Cancer Care Use of cannabinoids in cancer care: palliative care Abstract   PDF   HTML
S.K. Aggarwal
 
Vol 21, No 4 (2014) Use of chemotherapy and radiofrequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 years Abstract   PDF   HTML
N. Boame, G. Gresham, D. Jonker, G. Martel, F. Balaa, T. Asmis
 
Vol 21, No 3 (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline Abstract   PDF   HTML
X. Kostaras, F. Cusano, G.A. Kline, W. Roa, J. Easaw
 
Vol 21, No 1 (2014) Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy Abstract   PDF   HTML
S.P. Krotneva, A. Ramjaun, K.E. Reidel, T. Eguale, N. Trabulsi, N. Mayo, R. Tamblyn, A.N. Meguerditchian
 
Vol 23, No 5 (2016) Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data Abstract   PDF   HTML
K. Tran, R. Rahal, M. Brundage, S. Fung, C. Louzado, M. Milosevic, J. Xu, H. Bryant
 
Vol 21, No 6 (2014) Use of pet in the management of non-small-cell lung cancer in Canada Abstract   PDF   HTML
E. Vorauer, C. Louzado, K. DeCaria, J. Hernandez, R. Rahal, J. Niu, G. Lockwood, H. Bryant
 
Vol 24, No 2 (2017) Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer Abstract   PDF   HTML
C. Kendell, K.M. Decker, P.A. Groome, M.L. McBride, L. Jiang, M.K. Krzyzanowska, G. Porter, D. Turner, R. Urquhart, M. Winget, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
 
Vol 21, No 3 (2014) Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer Abstract   PDF   HTML
M. Mathews, D. Ryan, V. Gadag, R. West
 
Vol 25, No 6 (2018) Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting Abstract   PDF   HTML
S. Nazha, S. Tanguay, A. Kapoor, M. Jewett, C. Kollmansberger, L. Wood, G. Bjarnason, D. Heng, D. Soulières, N. Reaume, N. Basappa, E. Lévesque, A. Dragomir
 
Vol 22, No 3 (2015) Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review Abstract   PDF   HTML
P.M. Ellis, N. Coakley, R. Feld, S. Kuruvilla, Y.C. Ung
 
Vol 22, No 1 (2015) Use of the word “cured” for cancer patients—implications for patients and physicians: the Siracusa charter Abstract   PDF   HTML
P. Tralongo, L. Dal Maso, A. Surbone, A. Santoro, U. Tirelli, V. Sacchini, C. Pinto, S. Crispino, F. Ferraù, G. Mandoliti, G. Tonini, A. Russo, D. Santini, A. Madeddu, V. Panebianco, S. Pergolizzi, D. Respini, C. Rolfo, M. Bongiovanni, F. De Lorenzo, C. Spatola, F. Di Raimondo, M. Terenziani, M. Peeters, C. Castoro
 
Vol 24, No 4 (2017) User survey of Nanny Angel Network, a free childcare service for mothers with cancer Abstract   PDF   HTML
L. Cohen, N. Schwartz, A. Guth, A. Kiss, E. Warner
 
Vol 22, No 5 (2015) Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma Abstract   PDF   HTML
A. Schiavi, J. Lavigne, R. Turcotte, L. Karsprzak, N. Dumas, G. Chong, C. Freeman, M. Alameldin, P. Galiatsatos, L. Palma, W.D. Foulkes
 
Vol 18, No 2 (2011) Using a positive self-talk intervention to enhance coping skills in breast cancer survivors: lessons from a community based group delivery model Abstract   PDF   HTML
R. Hamilton, B. Miedema, L. MacIntyre, J. Easley
 
Vol 24, No 6 (2017) Using family history forms in pediatric oncology to identify patients for genetic assessment Abstract   PDF   HTML
A. Hamilton, E. Smith, J. Hamon, E. Tomiak, M. Bassal, S.L. Sawyer
 
Vol 21, No 6 (2014) Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review Abstract   PDF   HTML
M. Smoragiewicz, J. Laskin, D. Wilson, K. Ramsden, J. Yee, S. Lam, T. Shaipanich, Y. Zhai, C. Ho
 
Vol 22, No 3 (2015) Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience Abstract   PDF   HTML
E. Baxter, L. Gondara, C. Lohrisch, S. Chia, K. Gelmon, M. Hayes, A. Davidson, S. Tyldesley
 
Vol 22, No 5 (2015) Using tablet-based technology in patient education about systemic therapy options for early-stage breast cancer: a pilot study Abstract   PDF   HTML
E.R. Morgan, K. Laing, J. McCarthy, F. McCrate, M.D. Seal
 
Vol 22, No 2 (2015) Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada Abstract   PDF   HTML
A.J. Coldman, N. Phillips, J. Brisson, W. Flanagan, M. Wolfson, C. Nadeau, N. Fitzgerald, A.B. Miller
 
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada Abstract   PDF   HTML
C. Popadiuk, C.L. Gauvreau, M. Bhavsar, C. Nadeau, K. Asakawa, W.M. Flanagam, M.C. Wolfson, A.J. Coldman, S. Memon, N. Fitzgerald, J. Lacombe, A.B. Miller
 
Vol 22, No 5 (2015) Utilization of magnetic resonance imaging in breast cancer screening Abstract   PDF   HTML
D. Lin, L. Moy, D. Axelrod, J. Smith
 
Vol 21, No 3 (2014) Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease Abstract   PDF   HTML
J.A. Broomfield, J.N. Greenspoon, A. Swaminath
 
Vol 15, No 5 (2008) Validation of Symptom Clusters in Patients with Metastatic Bone Pain Abstract   PDF
Stephanie Hadi, Liying Zhang, Amanda Hird, Eric de Sa, Edward Chow
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada Abstract   PDF   HTML
J. Lemieux, S. Audet
 
Vol 25, No 2 (2018) Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario Abstract   PDF   HTML
K.E. Brennan, S.F. Hall, T.E. Owen, R.J. Griffiths, Y. Peng
 
Vol 21, No 4 (2014) Venous thromboembolism in cancer patients: a call for more awareness Abstract   PDF   HTML
A. Delluc, M. Carrier
 
Vol 23, No 4 (2016) Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia Abstract   PDF   HTML
H. Sibai, J.T. Seki, T.Q. Wang, N. Sakurai, E.G. Atenafu, K.W.L. Yee, A.C. Schuh, V. Gupta, M.D. Minden, A.D. Schimmer, J.M. Brandwein
 
Vol 17, No 2 (2010) Vera Peters and the conservative management of early-stage breast cancer Abstract   PDF
D. H. Cowan
 
Vol 15, No 5 (2008) Vera Peters and the curability of Hodgkin's disease. Abstract   PDF
Donald Henry Cowan
 
Vol 19, No 6 (2012) Views of breast and colorectal cancer survivors on their routine follow-up care Abstract   PDF   HTML
R. Urquhart, A. Folkes, J. Babineau, E. Grunfeld
 
Vol 22, No 4 (2015) Views of family physicians about survivorship care plans to provide breast cancer follow-up care: exploration of results from a randomized controlled trial Abstract   PDF   HTML
M.A. O'Brien, E. Grunfeld, J. Sussman, G. Porter, M. Hammond Mobilio
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Visions on Wellness from a Single Large Academic Institution to a Provincial Plan Abstract   PPT Presentation
Bob Bell, Terry Sullivan
 
Vol 24, No 6 (2017) Wait times for diagnosis and treatment of lung cancer: a single-centre experience Abstract   PDF   HTML
C. Labbé, M. Anderson, S. Simard, L. Tremblay, F. Laberge, R. Vaillancourt, Y. Lacasse
 
Vol 22, No 5 (2015) Wait times for prostate cancer treatment and patient perceptions of care in Canada: a mixed-methods report Abstract   PDF   HTML
K. Tran, C. Sandoval, R. Rahal, G. Porter, R. Siemens, J. Hernandez, S. Fung, C. Louzado, J Liu, H. Bryant
 
Vol 20, No 6 (2013) Weakly hormone receptor– positive breast cancer and use of adjuvant hormonal therapy Abstract   PDF   HTML
C.M. Lin, J. Jaswal, T. Vandenberg, A. Tuck, M. Brackstone
 
Vol 17, No 4 (2010) Weathering storms: a cohort study of how participation in a mindfulness based stress reduction program benefits women after breast cancer treatment Abstract   PDF
R.H. Matousek, P.L. Dobkin
 
Vol 18, No 1 (2011) Weekly paclitaxel in ovarian cancer—the latest success story Details   PDF   HTML
A. Jain, B. Dubashi, K.S Reddy, P. Jain
 
Vol 22, No 6 (2015) Wellness Beyond Cancer Program: Building an effective survivorship program Abstract   PDF   HTML
M. Rushton, R. Morash, G. Larocque, C. Liska, S. Stoica, C. Degrasse, R. Segal
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Wellspring: An Important Part of Integrative Health Care Abstract   PPT Presentation
Presenter Morrison
 
Vol 17, No 6 (2010) What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? Abstract   PDF
E. Yu, P. Tai, R. Malthaner, L. Stitt, G. Rodrigues, R. Dar, B. Yaremko, J. Younus, M. Sanatani, M. Vincent, B. Dingle, D. Fortin, R. Inculet
 
1501 - 1600 of 1627 Items << < 11 12 13 14 15 16 17 > >>